Paysign (NasdaqCM:PAYS) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Company ParticipantsGary Prestopino - Managing DirectorJeff Baker - CFOJon Hickman - Managing Director of Equity ResearchMark Newcomer - President and CEOMatt Turner - President of Patient AffordabilityConference Call ParticipantsJacob Stephan - Senior Research AnalystPeter Heckmann - Managing Director and Senior Research AnalystOperatorAs a reminder, this conference call is being recorded. The comments on today's call regarding Paysig ...

Paysign (NasdaqCM:PAYS) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Company ParticipantsGary Prestopino - Managing DirectorJeff Baker - CFOJon Hickman - Managing Director of Equity ResearchMark Newcomer - President and CEOMatt Turner - President of Patient AffordabilityConference Call ParticipantsJacob Stephan - Senior Research AnalystPeter Heckmann - Managing Director and Senior Research AnalystOperatorAs a reminder, this conference call is being recorded. The comments on today's call regarding Paysig ...

Paysign (NasdaqCM:PAYS) Q4 2025 Earnings call March 24, 2026 05:00 PM ET Speaker6As a reminder, this conference call is being recorded. The comments on today's call regarding Paysign's financial results will be on a GAAP basis, unless otherwise noted. Paysign's earnings release was disseminated to the SEC earlier today and can be found on the investor relations section of our website, paysign.com, which includes reconciliations of non-GAAP measures to GAAP-reported amounts. Additionally, as set forth in mor ...

Exhibit 99.1 Earnings Release Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion Mix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth HENDERSON, Nev. – March 24, 2026 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability offerings, donor compensation solutions, engagement and management platfo ...

Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion Mar 24, 2026 4:10 PM Eastern Daylight Time Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion Share Mix Shift Drives Gross and Operating Margin Expansion Strong Balance Sheet Enables Continued Investment for Profitable Growth HENDERSON, Nev.--(BUSINES ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Paysign, Inc. has announced a performance analysis for its Patient Affordability Solutions, focusing on the financial impact and effectiveness of its offerings in the healthcare sector [1] Group 1: Company Overview - Paysign, Inc. specializes in providing financial solutions aimed at improving patient affordability in healthcare [1] - The company is set to evaluate its performance metrics for 2025, indicating a forward-looking approach to its business strategy [1] Group 2: Industry Context - The healthcare industry is increasingly prioritizing patient affordability, making solutions like those offered by Paysign critical for both patients and providers [1] - The analysis will likely address how Paysign's solutions align with broader trends in healthcare financing and patient support [1]

Group 1 - Paysign, Inc. (PAYS) closed at $5.49, with a 7.4% gain over the past four weeks, and analysts set a mean price target of $9.1, indicating a 65.8% upside potential [1] - The mean estimate includes five short-term price targets with a standard deviation of $0.65, where the lowest estimate is $8.50 (54.8% increase) and the highest is $10.00 (82.2% increase) [2] - Analysts show strong agreement on the company's ability to report better earnings, with a positive trend in earnings estimate revisions, which is a strong indicator of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has increased by 9.1% over the past month, with one estimate going higher and no negative revisions [12] - PAYS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While the consensus price target may not be entirely reliable, the direction it implies appears to be a good guide for potential price movement [14]

Core Viewpoint - Paysign, Inc. (PAYS) shows potential for significant upside, with a mean price target of $9.1 indicating a 74% increase from its current price of $5.23 [1] Price Targets and Analyst Estimates - The mean estimate consists of five short-term price targets with a standard deviation of $0.65, suggesting a consensus among analysts [2] - The lowest estimate of $8.50 indicates a 62.5% increase, while the highest target of $10.00 suggests a 91.2% increase from the current price [2] - Analysts' price targets can be misleading, as they may not accurately reflect the stock's future price movements [3][7] Earnings Estimates and Analyst Agreement - There is strong agreement among analysts regarding PAYS's ability to report better earnings, which supports the potential for stock upside [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 2.9%, with one estimate moving higher and no negative revisions [12] - PAYS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a useful guide for the direction of price movement [14]

Core Viewpoint - Paysign, Inc. (PAYS) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [4]. Recent Performance and Outlook - For the fiscal year ending December 2025, Paysign is expected to earn $0.36 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 2.9% over the past three months [8]. - The upgrade to Zacks Rank 2 places Paysign in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [10]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - The system maintains a balanced distribution of ratings, ensuring that only the top 20% of stocks are positioned for superior earnings estimate revisions [9][10].